Literature DB >> 21123305

The effect of gadoxetic acid enhancement on lesion detection and characterisation using T₂ weighted imaging and diffusion weighted imaging of the liver.

S A Choi1, S S Lee, I-H Jung, H A Kim, J H Byun, M-G Lee.   

Abstract

OBJECTIVES: To evaluate the effect of gadoxetic acid enhancement on the detection and characterisation of focal hepatic lesions on T(2) weighted and diffusion weighted (DW) images.
METHODS: A total of 63 consecutive patients underwent T(2) weighted and DW imaging before and after gadoxetic acid enhancement. Two blinded readers independently identified all of the focal lesions using a five-point confidence scale and characterised each lesion using a three-point scale: 1, non-solid; 2, indeterminate; and 3, solid. For both T(2) weighted and DW imaging, the accuracies for detecting focal lesions were compared using the free-response receiver operating characteristic analysis; the accuracies for lesion characterisation were compared using the McNemar test between non-enhanced and gadoxetic acid-enhanced image sets. For hepatic lesions ≥ 1 cm, the lesion-to-liver contrast-to-noise ratio (CNR) and the apparent diffusion coefficient (ADC) were compared in the non-enhanced and enhanced image sets using the generalised estimating equations.
RESULTS: For both T(2) weighted and DW images, the accuracies for detecting focal lesions (p ≥ 0.52) and those for lesion characterisation (p ≥ 0.63) did not differ significantly between the non-enhanced and enhanced image sets. The lesion-to-liver CNR was significantly higher on enhanced DW images than on non-enhanced DW images (p=0.02), although the difference was not significant for T(2) weighted imaging (p=0.65). The mean ADC values of lesions did not differ significantly on enhanced and non-enhanced DW imaging (p=0.75).
CONCLUSION: The acquisition of T(2) weighted and DW images after administration of gadoxetic acid has no significant effect on the detection or characterisation of focal hepatic lesions, although it improves the lesion-to-liver CNR on DW images.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21123305      PMCID: PMC3473923          DOI: 10.1259/bjr/12929687

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  25 in total

1.  Focal hepatic lesion detection: comparison of four fat-suppressed T2-weighted MR imaging pulse sequences.

Authors:  M Kanematsu; H Hoshi; K Itoh; T Murakami; M Hori; H Kondo; R Yokoyama; H Nakamura
Journal:  Radiology       Date:  1999-05       Impact factor: 11.105

Review 2.  Artifacts and pitfalls in diffusion MRI.

Authors:  Denis Le Bihan; Cyril Poupon; Alexis Amadon; Franck Lethimonnier
Journal:  J Magn Reson Imaging       Date:  2006-09       Impact factor: 4.813

3.  Spatial localization accuracy of radiologists in free-response studies: Inferring perceptual FROC curves from mark-rating data.

Authors:  Dev Chakraborty; Hong-Jun Yoon; Claudia Mello-Thoms
Journal:  Acad Radiol       Date:  2007-01       Impact factor: 3.173

4.  Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging.

Authors:  P Reimer; E J Rummeny; H E Daldrup; T Hesse; T Balzer; B Tombach; P E Peters
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

5.  Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trial.

Authors:  Juha Halavaara; Josy Breuer; Carmen Ayuso; Thomas Balzer; Marie-France Bellin; Lennart Blomqvist; Rick Carter; Luigi Grazioli; Renate Hammerstingl; Alexander Huppertz; Gregor Jung; Denis Krause; Andrea Laghi; Edward Leen; Luciano Lupatelli; Luca Marsili; Julio Martin; E Scott Pretorius; Caroline Reinhold; Michael Stiskal; Alan H Stolpen
Journal:  J Comput Assist Tomogr       Date:  2006 May-Jun       Impact factor: 1.826

6.  Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants--initial experience.

Authors:  Chiao-Yun Chen; Chun-Wei Li; Yu-Ting Kuo; Twei-Shiun Jaw; Ding-Kwo Wu; Jo-Chi Jao; Jui-Sheng Hsu; Gin-Chung Liu
Journal:  Radiology       Date:  2006-03-28       Impact factor: 11.105

7.  MRI findings of focal eosinophilic liver diseases.

Authors:  Young-Kon Kim; Chong Soo Kim; Woo Sung Moon; Baik-Hwan Cho; Sang Yong Lee; Jeong Min Lee
Journal:  AJR Am J Roentgenol       Date:  2005-05       Impact factor: 3.959

Review 8.  MR contrast agents: physical and pharmacologic basics.

Authors:  Shao-Pow Lin; Jeffrey J Brown
Journal:  J Magn Reson Imaging       Date:  2007-05       Impact factor: 4.813

9.  Image quality and focal lesion detection on T2-weighted MR imaging of the liver: comparison of two high-resolution free-breathing imaging techniques with two breath-hold imaging techniques.

Authors:  Seung Soo Lee; Jae Ho Byun; Hye-Suk Hong; Seong Ho Park; Hyung Jin Won; Yong Moon Shin; Moon-Gyu Lee
Journal:  J Magn Reson Imaging       Date:  2007-08       Impact factor: 4.813

Review 10.  MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

Authors:  Christoph J Zech; Karin A Herrmann; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471

View more
  5 in total

Review 1.  Added value of diffusion-weighted acquisitions in MRI of the abdomen and pelvis.

Authors:  William A Moore; Gaurav Khatri; Ananth J Madhuranthakam; Robert D Sims; Ivan Pedrosa
Journal:  AJR Am J Roentgenol       Date:  2014-05       Impact factor: 3.959

Review 2.  Magnetic Resonanance Imaging of the Liver (Including Biliary Contrast Agents)-Part 2: Protocols for Liver Magnetic Resonanance Imaging and Characterization of Common Focal Liver Lesions.

Authors:  Andrea Agostini; Moritz F Kircher; Richard K G Do; Alessandra Borgheresi; Serena Monti; Andrea Giovagnoni; Lorenzo Mannelli
Journal:  Semin Roentgenol       Date:  2016-05-30       Impact factor: 0.800

Review 3.  Diffusion MRI in early cancer therapeutic response assessment.

Authors:  C J Galbán; B A Hoff; T L Chenevert; B D Ross
Journal:  NMR Biomed       Date:  2016-01-15       Impact factor: 4.044

4.  MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation.

Authors:  C S van Kessel; W B Veldhuis; M A A J van den Bosch; M S van Leeuwen
Journal:  Eur Radiol       Date:  2012-05-30       Impact factor: 5.315

Review 5.  Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.

Authors:  Yee Liang Thian; Angela M Riddell; Dow-Mu Koh
Journal:  Cancer Imaging       Date:  2013-12-30       Impact factor: 3.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.